StockWatch
·
Pharmaceuticals
Acquisitions8 Aug 2026, 06:10 pm

Anlon Healthcare Signs Share Swap Agreements for Acquisitions

AI Summary

Anlon Healthcare Limited has executed Share Swap Agreements (SSA) to acquire up to 32.52% stake in Apiqo Organics Private Limited (AOPL) and up to 43.33% stake in Bizotic Lifescience Private Limited (BLPL). The acquisitions will be made through the issuance of fresh equity shares on a preferential basis, without any cash consideration. AOPL is involved in manufacturing pharmaceutical intermediates and chemicals, with a turnover of ₹7,254.11 Lakh as of March 31, 2026. The acquisition aims to strengthen the supply of critical materials, achieve strategic synergies, and enhance shareholder value. The transactions are subject to necessary approvals and customary closing conditions, with completion expected within 90 days. The acquisitions are classified as related party transactions due to common promoters and directors but are conducted on an arm's length basis.

Key Highlights

  • Anlon Healthcare to acquire stakes in Apiqo Organics and Bizotic Lifescience.
  • Acquisitions to be settled via share swap, no cash involved.
  • Objective is to strengthen supply chain and achieve strategic synergies.
  • Transactions are related party but on an arm's length basis.
  • Acquisitions subject to regulatory approvals and closing conditions.